Clinical Trials Directory

Trials / Unknown

UnknownNCT05107830

Phenotyping of Primary Hyperoxaluria

Phenotyping of Primary Hyperoxaluria in Children and Adults

Status
Unknown
Phase
Study type
Observational
Enrollment
186 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers

Summary

985 / 5000 Résultats de traduction Primary hyperoxaluria is a rare autosomal recessive disease with an estimated prevalence of around 1 to 3 cases per million population. The most frequent attacks are urolithiasis disease and nephrocalcinosis, ultimately leading to end-stage chronic renal failure. The phenotype of this pathology is very heterogeneous, making the diagnosis difficult. There is currently a significant diagnostic delay. This is potentially due to atypical forms, or to insufficient clinicians' awareness of its research. However, the early diagnosis of this pathology is essential, since end-stage chronic renal failure can be avoided or at least delayed with early and appropriate management. The objective of the study is to describe the phenotype of currently diagnosed primary hyperoxaluria, in order to identify the classic presentations but also the characteristics of atypical presentations

Conditions

Timeline

Start date
2021-01-22
Primary completion
2023-01-01
Completion
2023-01-01
First posted
2021-11-04
Last updated
2021-11-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05107830. Inclusion in this directory is not an endorsement.